IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Indaptus Therapeutics Inc (INDP)

CUSIP: 45339J204 | NYSE | Healthcare · Biotechnology | Micro Cap | 20 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Geode Capital Management, LLC195,620
0.0% of portfolio›$449.9K
UBS Group AG83,363
0.0% of portfolio›$191.7K
Barclays PLC13,723
0.0% of portfolio›$31.6K
SBI Securities Co., Ltd.17
0.0% of portfolio›$39
Caitong International Asset Management Co., Ltd2
0.0% of portfolio›$5
Citigroup Inc1
0.0% of portfolio›$2
StyleTurnoverLocationFiled
Geode Capital Management, LLC
195,620$449.9K0.0%IndexVery LowBoston, MA2026-11-06
UBS Group AG
83,363$191.7K0.0%CoreMediumZurich, Switzerland2026-11-10
Barclays PLC
13,723$31.6K0.0%GrowthMediumLondon, United Kingdom2026-11-06
SBI Securities Co., Ltd.
17$390.0%GrowthLowTokyo, Mexico2026-10-22
Caitong International Asset Management Co., Ltd
2$50.0%GrowthVery HighHong Kong, South Korea2026-10-29
Citigroup Inc
1$20.0%CoreMediumNew York, NY2026-11-04